Undark Magazine  |  August 2, 2017

That strikes some public health advocates as a bit of foot-dragging. “A lot of these issues they’re raising that they say they have to consider have been considered, have been researched, have been studied,” says Eric Lindblom, director for tobacco control and food and drug law at the O’Neill Institute for National and Global Health Law at Georgetown University. Lindblom has a long resume for developing tobacco control policies to improve public health, including a 2011-2014 stint at the FDA’s Center for Tobacco Products.

“FDA saying that ‘We’re going to look into nicotine reduction,’ without also saying, ‘We’re going to issue a proposed rule before the end of this year, or before June of next year,’ just opens the door to continued discussion and talking and all the rest, without actually ever getting anything done,” Lindblom said.

Read more here.